These findings underscore the Gas6–AIM axis as a pivotal anti-inflammatory pathway in ALI/ARDS, providing insights into its potential as a therapeutic target for inflammatory lung diseases. This evidence concerns the gene GAS6 and acute respiratory distress syndrome.